---
title: "Two-year SWING data “continue to show promise” for sirolimus DCB in treating BTK disease"
date: "2023-11-16T15:09:37.000Z"
publishedDate: "16 novembre 2023"
summary: "Two-year data from the SWING trial, a first-in-human study of the safety and performance of the Sundance sirolimus drug-coated balloon (DCB; Surmodics), have been presented at this year&#8217;s VEITHsymposium (14–18 November, New York, USA). The SWING trial is a 35-patient prospective, multicentre, single-arm feasibility study to evaluate the safety and performance of the Sundance sirolimus [&#8230;] The post Two-year SWING data &#8220;continue to show promise&#8221; for sirolimus DCB in treating BTK disease appeared first on Interventional News ."
importance: ""
sourceUrl: "https://interventionalnews.com/two-year-swing-data-continue-to-show-promise-for-sirolimus-dcb-in-treating-btk-disease/"
tags: ["France", "Actualité", "Interventional News — Latest"]
permalink: "/papers/2023-11-16-two-year-swing-data-continue-to-show-promise-for-sirolimus-dcb-in-treating-btk-disease"
imageUrl: "https://interventionalnews.com/wp-content/uploads/sites/13/2023/11/Ramon-Varcoe-at-VEITH-2022.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://interventionalnews.com/two-year-swing-data-continue-to-show-promise-for-sirolimus-dcb-in-treating-btk-disease/"
---

![Two-year SWING data “continue to show promise” for sirolimus DCB in treating BTK disease](https://interventionalnews.com/wp-content/uploads/sites/13/2023/11/Ramon-Varcoe-at-VEITH-2022.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://interventionalnews.com/two-year-swing-data-continue-to-show-promise-for-sirolimus-dcb-in-treating-btk-disease/*

## L’essentiel

Two-year data from the SWING trial, a first-in-human study of the safety and performance of the Sundance sirolimus drug-coated balloon (DCB; Surmodics), have been presented at this year&#8217;s VEITHsymposium (14–18 November, New York, USA). The SWING trial is a 35-patient prospective, multicentre, single-arm feasibility study to evaluate the safety and performance of the Sundance sirolimus [&#8230;] The post Two-year SWING data &#8220;continue to show promise&#8221; for sirolimus DCB in treating BTK disease appeared first on Interventional News .

## Lien source

https://interventionalnews.com/two-year-swing-data-continue-to-show-promise-for-sirolimus-dcb-in-treating-btk-disease/
